NASDAQ:UTHR

United Therapeutics Stock Insider Trading

etoro logo Buy UTHR
*Your capital is at risk
$549.47
+9.42 (+1.74%)
At Close: Jun 03, 2026

United Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -90.70. In total, the insiders bought 145K and sold 72.98K UTHR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-90.70
Buy 145K shares
Sell 72.98K shares
15% Buy Activity
Moderate Negative Correlation
Buy Signal Low Confidence
Apr 01, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -90.7.
  • Confidence increased due to high data reliability score of 80.

Historical Insider Trades

Date Type Person Role Amount
Jun 01, 2026
Sell
Common Stock
S-Sale
Edgemond James
CFO And Treasurer
C-Suite Officer 2 520
Value: $1.38M
Jun 01, 2026
Sell
Common Stock
S-Sale
Edgemond James
CFO And Treasurer
C-Suite Officer 1 606
Value: $880.5K
Jun 01, 2026
Sell
Common Stock
S-Sale
Edgemond James
CFO And Treasurer
C-Suite Officer 400
Value: $221.8K
Jun 01, 2026
Sell
Common Stock
S-Sale
Edgemond James
CFO And Treasurer
C-Suite Officer 280
Value: $154.8K
Jun 01, 2026
Sell
Common Stock
S-Sale
Rothblatt Martine A
Chairperson & CEO
CEO / President 2 213
Value: $1.21M
Jun 01, 2026
Sell
Common Stock
S-Sale
Rothblatt Martine A
Chairperson & CEO
CEO / President 1 376
Value: $752.8K
Jun 01, 2026
Sell
Common Stock
S-Sale
Rothblatt Martine A
Chairperson & CEO
CEO / President 1 546
Value: $847.5K
Jun 01, 2026
Buy
Common Stock
M-Exempt
Edgemond James
CFO And Treasurer
C-Suite Officer 10 000
Value: $1.18M
Jun 01, 2026
Sell
Common Stock
S-Sale
Edgemond James
CFO And Treasurer
C-Suite Officer 1 440
Value: $784.7K
Jun 01, 2026
Buy
Stock Option
M-Exempt
Edgemond James
CFO And Treasurer
C-Suite Officer 10 000
Value: $1.18M
Jun 01, 2026
Buy
Common Stock
M-Exempt
Rothblatt Martine A
Chairperson & CEO
CEO / President 9 500
Value: $1.39M
Jun 01, 2026
Sell
Common Stock
S-Sale
Rothblatt Martine A
Chairperson & CEO
CEO / President 240
Value: $132.7K
Jun 01, 2026
Sell
Common Stock
S-Sale
Rothblatt Martine A
Chairperson & CEO
CEO / President 124
Value: $68.3K
Jun 01, 2026
Buy
Stock Option
M-Exempt
Rothblatt Martine A
Chairperson & CEO
CEO / President 9 500
Value: $1.39M
Jun 01, 2026
Sell
Common Stock
S-Sale
Rothblatt Martine A
Chairperson & CEO
CEO / President 1 166
Value: $640.5K
Jun 01, 2026
Sell
Common Stock
S-Sale
Edgemond James
CFO And Treasurer
C-Suite Officer 1 015
Value: $558.4K
Jun 01, 2026
Sell
Common Stock
S-Sale
Edgemond James
CFO And Treasurer
C-Suite Officer 1 185
Value: $650.9K
Jun 01, 2026
Sell
Common Stock
S-Sale
Rothblatt Martine A
Chairperson & CEO
CEO / President 400
Value: $221.8K
Jun 01, 2026
Sell
Common Stock
S-Sale
Rothblatt Martine A
Chairperson & CEO
CEO / President 1 070
Value: $588.8K
Jun 01, 2026
Sell
Common Stock
S-Sale
Rothblatt Martine A
Chairperson & CEO
CEO / President 1 365
Value: $744.0K
Jun 01, 2026
Sell
Common Stock
S-Sale
Edgemond James
CFO And Treasurer
C-Suite Officer 1 354
Value: $740.8K
Jun 01, 2026
Sell
Common Stock
S-Sale
Edgemond James
CFO And Treasurer
C-Suite Officer 200
Value: $110.2K
May 29, 2026
Sell
Common Stock
S-Sale
Rothblatt Martine A
Chairperson & CEO
CEO / President 817
Value: $453.1K
May 29, 2026
Sell
Common Stock
S-Sale
Rothblatt Martine A
Chairperson & CEO
CEO / President 841
Value: $470.0K
May 29, 2026
Sell
Common Stock
S-Sale
Rothblatt Martine A
Chairperson & CEO
CEO / President 918
Value: $512.1K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT UNITED THERAPEUTICS CORPORATION
United Therapeutics
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Tyvaso, an inhaled formulation of prostacyclin a...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE